Dietary Supplements

Browse Dietary Supplements Content

Consumer Healthcare Products Association (CHPA) responds to findings from the “Supplements, Placebo, or Rosuvastatin (SPORT)” Study published in the Journal of the American College of Cardiology.

Nov 6, 2022

Jay Sirois, PhD, CHPA’s vice president of regulatory & scientific affairs, and co-author of the paper, Considerations for determining safety of probiotics: A USP perspective

Oct 27, 2022

(WASHINGTON, DC) – Consumer Healthcare Products Association (CHPA) President and CEO, Scott Melville, today released the below statement following congressional passage of a short-term spending package to fund the Federal Government through Dec. 16. Included in this Continuing Resolution is legislation to reauthorize the U.S. Food and Drug Administration’s (FDA) user fee programs for prescription drugs, generic drugs, biosimilars, and medical devices over the next five years.

Sep 30, 2022

Filter Results